E-Clinical and regulatory solutions and services provider Calyx has launched the Supply Simulation Service for forecasting and optimising clinical trial supplies.

Available through the company’s in-house statistical design and trial supplies consultants, the new service helps sponsors improve clinical trial efficiencies.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It helps to predict how long an existing amount of study medication will last, as well as evaluate the quantity of medication required for commencing and maintaining clinical trial enrolment, and determine optimal site and depot buffer stock quantities.

The service also enables companies to balance the cost of shipments and reduce the burden of excessive wastage of drugs.

Calyx Supply Simulation uses simulation modelling methodology and more than 50 design parameters, which mimic an Interactive Response Technology (IRT) system.

It evaluates the impact of protocol amendments and considers several real-life, fixed, and variable domains, as well as ‘what if’ scenarios, which frequently occur during clinical trials.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Calyx operations vice-president Juan Munoz Pujol said: “We’re pleased to offer this valuable service so that global clinical trial sponsors can reduce the risk of drug availability impacting their clinical studies as patients progress through the dispensing events of clinical trials.

“In addition, by optimising supply requirements upfront with Calyx Supply Simulation, sponsors can minimise the amount of drugs that end up destroyed during clinical trials, which will reduce excessive drug wastage and help sponsors meet their corporate sustainability goals.”

The expert supply chain analysts’ team of the company works with each trial sponsor to understand their specific challenges and adapt the new service to meet their requirements.

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
Science 37 has won the Research and Development Award in the Site Innovation category for its FDA inspected Direct-to-Patient Site model, delivering nationwide access, faster enrollment and higher retention. Explore how its virtual-first, in home approach is reshaping trial operations and accelerating time to data-driven decisions..

Discover the Impact